Patent ID: 6048844
Filing Date: 2000-04-11
Classification: A61K,A61P,Y10S

Abstract:
A method of treating a condition or disease in a mammal involving tissue selected from the group consisting of underperfused tissue and pathological tissue comprising administering to the mammal a therapeutically effective dosage amount of an agent selected from the group consisting of a medicine and a therapeutic agent and combinations thereof to treat the disease or condition and a sufficient amount of a form of hyaluronic acid selected from the group consisting of hyaluronic acid and its non-toxic salts and combinations thereof sufficient to facilitate the penetration of the agent through the tissue at a site to be treated through the cell membranes into the individual cells to be treated wherein the molecular weight of the form of hyaluronic acid is in the range of 150,000 to 750,000 daltons, and said amount of the form of hyaluronic acid is sufficient to provide a dosage greater than 10 mg and less than 1000 mg.